phone icon(716) 674-6030 fax icon(716) 674-6052
bill pay iconPay Your Bill
Receive our Health e-Newsletter
  Home  
  Our Team  
  Patient Info  
  Services  
   
  Patient Info  

News for Healthier Living

Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

March 24, 2026


April 4 2026

April 3 2026

April 2 2026

April 1 2026

March 31 2026

March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026